1. Home
  2. BRTX vs CHGA Comparison

BRTX vs CHGA Comparison

Compare BRTX & CHGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.55

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Logo Change Agents Corporation Common Stock

CHGA

Change Agents Corporation Common Stock

BUY

Current Price

$1.56

Market Cap

3.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BRTX
CHGA
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
3.0M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
BRTX
CHGA
Price
$1.55
$1.56
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $160.00
N/A
AVG Volume (30 Days)
32.2K
★ 67.7K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.18
EPS
★ N/A
N/A
Revenue
★ $81,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$383.87
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.14
$0.25
52 Week High
$34.00
$3.02

Technical Indicators

Market Signals
Indicator
BRTX
CHGA
Relative Strength Index (RSI) 33.02 43.56
Support Level $0.14 $0.25
Resistance Level $2.93 $2.54
Average True Range (ATR) 0.20 0.25
MACD -0.00 -0.11
Stochastic Oscillator 21.70 22.31

Price Performance

Historical Comparison
BRTX
CHGA

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

About CHGA Change Agents Corporation Common Stock

Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.

Share on Social Networks: